Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies
Tam Binh V. Bui, Denise M. Wolf, Michael C. Bruck, Kaitlin Moore, Jessica Lien, Sarah D.W. Choi, Shruti Warhadpande, Amirabbas Parizadeh, Deborah A. R. Dillon, Beth A. Overmoyer, Filipa C. Lynce, I-SPY 2 Investigators, Isaäc J. Nijman, Boudewijn M.T. Burgering, Isaac S. Harris, , Jennifer M. Rosenbluth
The paper develops predictive models using patient-derived breast cancer organoids to identify drug responses and guide new therapies for resistant disease.
bioRxiv · Aug 24, 2025 · PreprintCancer Biology